217 filings
Page 5 of 11
8-K
74zhanmj3p0
22 Feb 07
AtheroGenics Reports Fourth Quarter and Year-End 2006 Financial Results
12:00am
8-K
t5lxivjm s7u1a0q9pya
9 Jan 07
AtheroGenics Refines Timing of ARISE Clinical Trial Top-line Results
12:00am
8-K
l2j 8vznb
4 Jan 07
Departure of Directors or Principal Officers
12:00am
8-K
r429fglf m6tsqzkvy
8 Dec 06
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
4k6kvvcagb2e wn24
24 Oct 06
AtheroGenics Reports Third Quarter 2006 Financial Results
12:00am
8-K
360y55no9vq0e9 ll
29 Sep 06
Entry into a Material Definitive Agreement
12:00am
8-K
4gvrnhrvos8d4t8f
20 Jul 06
AtheroGenics Reports Second Quarter 2006 Financial Results
12:00am
8-K
83kqjx adhw3h
18 Jul 06
AtheroGenics, Inc. Announces Two New Board Members
12:00am
8-K
7dp 09wisv0505jp
6 Jul 06
AtheroGenics Announces Promotion of Joseph M. Gaynor, Jr. to Senior Vice President
12:00am
8-K
owd9 b21pzs4hj5
22 May 06
AtheroGenics Announces Dismissal of Class Action Litigation
12:00am
UPLOAD
d7d62u13qthb
16 May 06
Letter from SEC
12:00am
8-K
ypbtuefd7le1yg
20 Apr 06
AtheroGenics Reports First Quarter 2006 Financial Results
12:00am
CORRESP
9r26qt
31 Mar 06
Correspondence with SEC
12:00am
ARS
8viqhi ru177ox6a75ah
27 Mar 06
Annual report to shareholders
12:00am
UPLOAD
8un5vnao
23 Mar 06
Letter from SEC
12:00am